LESION CODING: Confused by Recent Lesion Coding Directives From NGS? Here's the Scoop

Why This Topic Matters

The topic matters because payer guidance can affect diagnosis selection, documentation expectations, and whether a lesion excision is coded as benign or malignant. Practices need to know when official contractor guidance is being revised and how that affects claims workflow and record review.

Article Sections

1. Decipher the NGS LCD

   This section reviews the disputed Medicare contractor language and the coding context that prompted concern among providers. It frames the issue around lesion excision billing, diagnosis coding, and documentation expectations.

2. NGS Officials Promise Correction

   This section summarizes the contractor’s stated plan to remove the disputed language and issue clarification. It also notes the interim status of the guidance and the need to watch for an official notice.

3. Bottom line

   This section provides the article’s closing takeaway about following the applicable coding guidance and awaiting supporting pathology information. It also points readers toward the broad code families referenced in the discussion.